Cerebrospinal fluid metabolomics reveals predictive biomarkers of nusinersen therapy efficacy in type II and type III spinal muscular atrophy patients
| Title: | Cerebrospinal fluid metabolomics reveals predictive biomarkers of nusinersen therapy efficacy in type II and type III spinal muscular atrophy patients |
|---|---|
| Authors: | Li, DanAff1; Sun, NaAff1; Wu, HongboAff1; Wang, XueyingAff1; Shi, YongjingAff1; Yang, LinAff1; Huang, ShaopingAff1; Zhang, KunAff2, IDs10072025082678_cor1; Yang, ChanghongAff1, IDs10072025082678_cor2 |
| Source: | Neurological Sciences. 46(10):5145-5159 |
| Database: | Springer Nature Journals |